Your browser doesn't support javascript.
loading
Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.
Terry, Stéphane; Dalban, Cécile; Rioux-Leclercq, Nathalie; Adam, Julien; Meylan, Maxime; Buart, Stéphanie; Bougoüin, Antoine; Lespagnol, Alexandra; Dugay, Frédéric; Moreno, Irelka Colina; Lacroix, Guillaume; Lorens, James B; Gausdal, Gro; Fridman, Wolf H; Mami-Chouaib, Fathia; Chaput, Nathalie; Beuselinck, Benoit; Chabaud, Sylvie; Barros-Monteiro, Janice; Vano, Yann; Escudier, Bernard; Sautès-Fridman, Catherine; Albiges, Laurence; Chouaib, Salem.
Affiliation
  • Terry S; INSERM UMR 1186, Integrative Tumour Immunology and Immunotherapy, Gustave Roussy, Université Paris-Saclay, Villejuif, France. stephane.terry@gustaveroussy.fr salem.chouaib@gustaveroussy.fr.
  • Dalban C; Department of Clinical Research and Innovation, Centre de Lutte Contre Le Cancer, Centre Léon Bérard, Lyon, France.
  • Rioux-Leclercq N; Service Anatomie et Cytologie Pathologiques, CHU Rennes, Université de Rennes, Institut de Recherche en Santé, Environnement et Travail (Irset) - Inserm UMR 1085, Rennes, France.
  • Adam J; INSERM UMR 1186, Integrative Tumour Immunology and Immunotherapy, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Meylan M; Centre de Recherche des Cordeliers, Equipe inflammation Complément et Cancer, Sorbonne Université, Inserm, Université de Paris, Paris, France.
  • Buart S; INSERM UMR 1186, Integrative Tumour Immunology and Immunotherapy, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Bougoüin A; Centre de Recherche des Cordeliers, Equipe inflammation Complément et Cancer, Sorbonne Université, Inserm, Université de Paris, Paris, France.
  • Lespagnol A; Génétique Clinique, CHU Rennes, Université de Rennes, Rennes, France.
  • Dugay F; Laboratoire de Cytogénétique et Biologie Cellulaire, CHU Rennes, Institut de Recherche en Santé, Environnement et Travail (Irset) - Inserm UMR 1085, EHESP, Université de Rennes, Rennes, France.
  • Moreno IC; Centre de Recherche des Cordeliers, Equipe inflammation Complément et Cancer, Sorbonne Université, Inserm, Université de Paris, Paris, France.
  • Lacroix G; Centre de Recherche des Cordeliers, Equipe inflammation Complément et Cancer, Sorbonne Université, Inserm, Université de Paris, Paris, France.
  • Lorens JB; Centre for Cancer Biomarkers, Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Gausdal G; BerGenBio, Bergen, Norway.
  • Fridman WH; Centre de Recherche des Cordeliers, Equipe inflammation Complément et Cancer, Sorbonne Université, Inserm, Université de Paris, Paris, France.
  • Mami-Chouaib F; INSERM UMR 1186, Integrative Tumour Immunology and Immunotherapy, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Chaput N; Laboratory of Immunomonitoring in Oncology, Gustave Roussy, CNRS-UMS 3655 and INSERM-US23, Villejuif, France.
  • Beuselinck B; Faculty of Pharmacy, University Paris-Saclay, Chatenay-Malabry, Paris, France.
  • Chabaud S; Laboratory of Genetic Instability and Oncogenesis, UMR CNRS 8200, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Barros-Monteiro J; Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Vano Y; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Escudier B; Department of Clinical Research and Innovation, Centre de Lutte Contre Le Cancer, Centre Léon Bérard, Lyon, France.
  • Sautès-Fridman C; Research and Development, Unicancer, Paris, France.
  • Albiges L; Centre de Recherche des Cordeliers, Equipe inflammation Complément et Cancer, Sorbonne Université, Inserm, Université de Paris, Paris, France.
  • Chouaib S; Medical Oncology, Hôpital Européen Georges Pompidou, Assistance Publique - Hôpitaux de Paris, Université de Paris, Paris, France.
Clin Cancer Res ; 27(24): 6749-6760, 2021 12 15.
Article in En | MEDLINE | ID: mdl-34407968

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2021 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2021 Document type: Article Country of publication: Estados Unidos